Loading company…
Manteia develops medical systems and software for adaptive radiation therapy.
Founded in 2017 in Xiamen, China, Manteia develops adaptive radiation therapy systems, including AccuContour, Online ART-TPS and ARTCheck. Its products have received US FDA, China NMPA Class III, European CE and Korean KFDA registration certification. In January 2024, it raised CNY 110 million in Series B funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in